Clinical

Dataset Information

0

Phase II Study of Perindopril and Regorafenib in mCRC


ABSTRACT: The purpose of this study is to find out what effects the combination of regorafenib and perindopril has on hand-foot skin reaction (HFSR), on high blood pressure (hypertension) and on any other types of side-effects and compare it to the published incidence of the side-effects with regorafenib alone. This research is being done in an attempt to reduce the side-effects associated with regorafenib.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2205892 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2012-10-01 | GSE37474 | GEO
2013-11-27 | E-GEOD-52780 | biostudies-arrayexpress
2012-10-01 | E-GEOD-37474 | biostudies-arrayexpress
2013-11-27 | GSE52780 | GEO
2022-10-13 | PXD034073 | Pride
| 37419 | ecrin-mdr-crc
2013-07-03 | E-GEOD-38732 | biostudies-arrayexpress
2024-05-16 | GSE186996 | GEO
2013-07-03 | E-GEOD-39131 | biostudies-arrayexpress
2020-08-17 | PXD020929 |